Presented by:
Sponsored by:

Advances in precision medicine and genomic sequencing

Now available on demand


Next-generation sequencing platforms are opening up new opportunities in precision medicine by dramatically reducing the cost and time to access large volumes of genomic data.
This webcast will highlight innovative technologies being developed by companies in the field, and how they are laying the groundwork for novel therapeutics and diagnostics in areas such as oncology and rare diseases. The topics will include advanced bioinformatics and next-generation sequencing for pathogen detection, nanosensor technology for genome sequencing and healthcare diagnostics, molecular indexing technology for digital detection of single cells and cloud-based accelerated genomics analysis.

The webcast will conclude with a live roundtable discussion and a Q&A section to allow you to hear the views of the speakers and to put your own questions to them.

BioPharma Dealmakers webcasts are dedicated to small and large companies looking for commercial partnerships. Read the quarterly BioPharma Dealmakers supplement in Nature Biotechnology and Nature Reviews Drug Discovery.

Webcast sponsors retain sole responsibility for content.

Presenter
Bharath Takulapalli
Founder and CEO
INanoBio
View Biography
Presenter
Crystal R Icenhour
Co-Founder and CEO
Aperiomics, Inc.
View Biography
Presenter
Hans Cobben
CEO
Bluebee
View Biography
Presenter
Jonathan Seaton
Vice President of Strategy and Business Development, Life Sciences
Becton Dickinson
View Biography
Presenter
Moderator: Raveena Bhambra
Editor
BioPharma Dealmakers

Registration Details:

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

(*) denotes required form field(s)

Submit